Optomed Oyj Past Earnings Performance
Past criteria checks 0/6
Optomed Oyj's earnings have been declining at an average annual rate of -14.5%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 0.1% per year.
Key information
-14.5%
Earnings growth rate
-2.0%
EPS growth rate
| Medical Equipment Industry Growth | 28.7% |
| Revenue growth rate | 0.1% |
| Return on equity | -24.3% |
| Net Margin | -44.0% |
| Next Earnings Update | 13 Feb 2025 |
Recent past performance updates
Recent updates
Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?
Sep 27
Earnings Update: Here's Why Analysts Just Lifted Their Optomed Oyj (HEL:OPTOMED) Price Target To €6.63
May 11Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 26% Share Price Boost
May 10Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost
Mar 22Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts
Feb 18Market Cool On Optomed Oyj's (HEL:OPTOMED) Revenues
Dec 21Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?
Nov 15Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts
Aug 09Investors Continue Waiting On Sidelines For Optomed Oyj (HEL:OPTOMED)
Jun 01Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?
Oct 27Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?
Apr 23Revenue & Expenses Breakdown
How Optomed Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 14 | -6 | 9 | 0 |
| 30 Jun 24 | 15 | -5 | 9 | 0 |
| 31 Mar 24 | 15 | -4 | 9 | 0 |
| 31 Dec 23 | 15 | -4 | 9 | 0 |
| 30 Sep 23 | 15 | -4 | 9 | 0 |
| 30 Jun 23 | 15 | -5 | 10 | 0 |
| 31 Mar 23 | 15 | -5 | 10 | 0 |
| 31 Dec 22 | 15 | -5 | 10 | 0 |
| 30 Sep 22 | 14 | -6 | 10 | 0 |
| 30 Jun 22 | 14 | -5 | 9 | 0 |
| 31 Mar 22 | 14 | -5 | 9 | 0 |
| 31 Dec 21 | 15 | -4 | 9 | 0 |
| 30 Sep 21 | 15 | -3 | 9 | 0 |
| 30 Jun 21 | 15 | -2 | 8 | 0 |
| 31 Mar 21 | 14 | -3 | 8 | 0 |
| 31 Dec 20 | 13 | -3 | 8 | 0 |
| 30 Sep 20 | 13 | -3 | 8 | 0 |
| 30 Jun 20 | 13 | -4 | 8 | 0 |
| 31 Mar 20 | 15 | -4 | 8 | 0 |
| 31 Dec 19 | 15 | -3 | 8 | 0 |
| 30 Sep 19 | 16 | -2 | 7 | 0 |
| 31 Dec 18 | 14 | -1 | 6 | 0 |
| 31 Dec 17 | 7 | -3 | 4 | 0 |
| 31 Dec 16 | 7 | -3 | 4 | 0 |
Quality Earnings: OPTOMED is currently unprofitable.
Growing Profit Margin: OPTOMED is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OPTOMED is unprofitable, and losses have increased over the past 5 years at a rate of 14.5% per year.
Accelerating Growth: Unable to compare OPTOMED's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OPTOMED is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).
Return on Equity
High ROE: OPTOMED has a negative Return on Equity (-24.25%), as it is currently unprofitable.